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ABSTRACT
The Peste des petits ruminants (PPR) is a viral disease which affects sheep and goats and even the wild ruminants. About
a billion small ruminants are found in the PPR enzootic areas. Morbilliviruses are primarily lymphotropic and
secondarily epitheliotropic. Viral infection and interaction of viral proteins with lymphatic tissues are partly responsible
for immune suppression. Transient immunosuppression is also observed after vaccination with attenuated vaccines. Viral
isolation is traditionally done on Vero but newer recombinant cell lines are also used. In this work, sensitivity of three
cell lines i.e. SLAM-ve-Vero, Vero.DogSLAMtag and B95a having Marmoset SLAM have been compared for PPRV
titration. Moreover, infectivity of phytohemagglutinin (PHA) stimulated peripheral blood mononuclear cells (PBMCs)
with PPR virus (PPRV) has been tested. Finally, live PPRV, recombinant nucleoprotein of PPR Virus (NPPRV) and
truncated ∆420-525 NPPRV have been used to demonstrate in vitro inhibition of PHA stimulated lymphoproliferation of
PBMCs of naïve goats. The presence of canine SLAM (Signaling lymphocyte activation molecule) receptor but not the
marmoset SLAM, enhances infectivity of cell lines by up to 0.8 log10. At multiplicity of infection (MOI) of 0.1, 83.6
percent of PBMCs can be infected with PPRV. PPRV could completely inhibit lymphoproliferation at MOI of 0.75 while
NPPRV and ∆420-525 NPPRV could suppress lymphoproliferation by 7.4 % and 17.6 %, respectively. PPRV is
lymphotropic as PPRV (Nigeria 75/1) is capable of infecting mitogen activated PBMCs and that presence of canine
SLAM in Vero cell line greatly enhances infectivity of PPRV as compared to SLAM negative Vero. Vero.DogSLAMtag
is more sensitive cell line for PPRV titration and PPRV isolation. PPRV (Nigeria 75/1) and recombinant N-proteins
induce in vitro inhibition of cell proliferation of mitogen stimulated PBMCs of naive goats. Using deleted mutant of
NPPRV expressed in baculovirus system, amino acid sequence of NPPRV between 1-420 was found responsible for
inducing immune suppression.
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INTRODUCTION
Peste des petits ruminants (PPR) is a highly
contagious acute viral disease of small ruminants
clinically characterized by fever, occulo-nasal discharges,
stomatitis, diarrhea and pneumonia with foul offensive
breath (Griffin and Pan, 2009). It is caused by the virus of
Peste des Petits Ruminants (PPRV), which belongs to the
genus Morbillivirus and family Paramyxoviridae.
Morbidity rate of 90% and mortality rate of 50–80% may
occur in susceptible populations. Like other viruses in the
Morbillivirus genus, PPRV is also primarily
lymphotropic and secondarily epitheliotropic (Birch et
al., 2013; Pope et al., 2013). The viral tropism is also
manifested by the clinical signs like occulo-nasal
discharges, diarrhea, oral erosive lesions, marked
immuno-suppression, and leucopenia; while viral antigen
can be found in lymphoid organs and epithelial tissues of
the affected animals (Kumar et al., 2004; Birch et al.,
2013; Pope et al., 2013). The signaling lymphocyte
activation molecule (SLAM) or CD150, is the primary
receptor for PPRV (Pawar et al., 2008), which is found
on activated T cells, B cells, thymocytes, macrophages
and dendritic cells while an epithelial Nectin-4 protein
receptor has recently been discovered (Birch et al., 2013;
Pope et al., 2013).
Although Morbillivirus infections generate
strong immune responses with resulting long term
immunity, paradoxically, during temporary phase post-
infection they also produce an immunosuppression with
the emergence of secondary infections (Beckford et al.,
1985; Griffin, 2010). PPRV infection in small ruminants
also produces an impairment of cellular and humoral
immune functions, resulting in frequent opportunistic
infections (Mondal et al., 2001; Kumar et al., 2004). The
immune suppression is not only observed during natural
infections but also after vaccination with attenuated
strains of Morbilliviruses (Hussey et al., 1996; Stevenson
et al., 1999; Lund et al., 2000). The leucopenia and
immunosuppression result from a combination of factors
like cell death caused by infection of lymphocytes and
apoptosis, and the cell cycle arrest, caused by exposure to
the viral haemagglutinin and fusion surface glycoproteins
as well as viral nucleoprotein, expressed from the
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damaged cells (Mondal et al., 2001; Kumar et al., 2004;
Griffin 2010).
The nucleocapsid (N) protein of morbilliviruses
is a major viral protein both in the virion and in the
infected cell (Rima, 1983). NPPRV consists of 525 amino
acid residues and has a molecular weight of about 60 kDa
(Diallo et al., 1987; Diallo et al., 1994). It is a structural
protein which encapsidates the viral genome into an
RNAse-resistant nucleocapsid (the template for RNA
synthesis) and together with phosphoprotein forms the
ribonucleoprotein, which constitutes the minimum
essential for transcription and replication of viral genome
in the cell cytoplasm (Knipe and Howley, 2001).
Morbillivirus N protein consists of two domains; i.e. a
conserved N-terminal moiety (NCORE, aa 1–400) and a
variable C-terminal moiety (NTAIL, aa 401–525) (Diallo et
al., 1994). The region involved in nucleoprotein receptor
(NR) binding is localized within the hyper variable N-
terminal region of Measles virus (MeV) N. NTAIL binds
with the NR found on both T and B lymphocytes to
induce a cell cycle arrest and suppression of cell
proliferation (Laine et al., 2007 ). The NR specifically
binds with aa 401-420, that is well conserved among
Morbilliviruses (Diallo et al., 1994).
In this study, infectability of goat peripheral
blood mononuclear cells (PBMCs) with PPRV has been
evaluated in vitro. Moreover, susceptibility of one
SLAM-ve cell line (Vero) along with two cell lines
(Vero.DogSLAMtag and B95a) having Marmoset and
canine SLAM receptors, respectively, have been
compared through viral titration. Finally, the
immunosuppressive property of PPRV, NPPRV and the
truncated ∆420-525 NPPRV has been studied in vitro.
MATERIALS AND METHODS
Cell culture: Peripheral blood mononuclear cells
(PBMCs) of naive goats were isolated on Histopaque®-
1077 (Sigma- Aldrich, Inc., USA) density gradient and
cultured in RPMI medium supplemented with 0.5%
gentamycin, 1% glutamine, 0.1% mercaptoethanol and
10% fetal calf serum (FCS). The viability of cells was
assessed through trypan blue dye exclusion. B95a cells
were cultured in Dulbecco's Modified Eagle's Medium
(DMEM, Sigma) supplemented with 1% Glutamine, and
10% (v/v) FCS. Vero cells were maintained in Eagle's
minimum essential medium (EMEM) supplemented with
1% Glutamine, and 10% (v/v) FCS. Vero.DogSLAMtag
were cultured in RPMI 1640 containing 10% FCS. SF21
(Spodoptera frugiperda passage 21) cells were cultured
in Grace’s culture medium supplemented with 10% (v/v)
FCS. All cells were incubated in a humidified incubator
at 370C with 5% CO2 except SF21 cells which were
incubated at 270C without CO2.
PPRV production, titration and immunofluorescence
staining: PPRV (Nigeria-75/1), used for infecting
PBMCs and lympho proliferation studies, was produced
and titrated using Vero cells. Part of produced PPRV was
6-fold concentrated using the Centricon plus-70 filter,
(Millipore Corp., Bedford, MA). Moreover, viral
titrations on three cell lines were performed under level-3
biosecurity conditions. Calculations were done in
accordance with Reed-Muench method (Reed and
Muench, 1938). The PPRV strains Nigeria-75/1 and
Ethiopia-95/1 were serially 10 fold diluted in DMEM and
each dilution was transferred to 96 well cell culture plates
already having 2.5x 104 Vero, Vero.DogSLAMtag or
B95a cells /well. Viral infection was evaluated by
observation of cytopathic effect as well as immuno-
staining on day-9. Briefly, media were removed and 150
µl cold acetone 80% was added to each well and
incubated at -20°C for 30 minutes. Then, acetone was
removed and wells were washed thrice with PBS. 100 µl
1% Paraformaldehyde (PFA) was added to each well and
kept at room temperature for 30 minutes. The plates were
then moved from level-3 biosecurity laboratory to the
level-2 biosecurity facility. PFA was removed and wells
were washed thrice with PBS. Anti-PPRV mab (38-4)
diluted to 1:450 in PBS-1X was added to all wells. Plates
were washed with PBS thrice and the conjugate anti-
mouse diluted to 1:100 in PBS-1X was added to all wells.
Finally, plates were washed thrice with PBS and 50µl of
PBS was added to each well. Plates were observed under
inverted fluorescent microscope to calculate PPRV titers.
Baculoviral clone selection and expression
recombinant entire (N-PPRV) and truncated
nucleoprotein of PPRV (∆420-525N-PPRV):
Recombinant baculoviruses expressing NPPRV and
∆420-525 NPPRV were kindly gifted by Dr. Charles
Bojo. Clones of the two recombinant baculoviruses
expressing NPPRV and ∆420-525NPPRV proteins were
separately purified by plaque assay using agarose overlay
in 6-well cell culture plates. These were amplified
initially in confluent 6-well cell culture plates and
verified by immunoflourescence staining. Briefly,
infected SF21 cells were scrapped and transfered to 96-
well culture plates. These were fixed in 80% acetone at
room temperature for 30 minutes and were then rinced in
PBS. These were first reacted with anti-NPPRV
monoclonal antibody (MAB) 38.4 (IgG1 isotype) (Libeau
et al., 1995) for 30 minutes and washed twice with PBS.
Then, these were stained with FITC labeled anti-mouse-
IgG cojugate (dilution 1/80, Biorad). After washing, these
were observed under fluoresecnet microscope to verify
positive clones. These clones were then used to infect
confluent T-75 flasks at MOI of 10.  Four days later when
cytopathic effects were evident, supernatents were
discarded as nucleoprotein is intra-cytoplasmic. The cell
layer was washed twice with PBS, the monolayer was
Nizamani et al., J. Anim. Plant Sci. 24(5):2014
1382
scrapped and resuspended in 15 ml of PBS. The cell
suspensions were freeze-thawed (-800C and 370C) thrice.
The lysates were 6-fold concentrated using the Centricon
plus-70 filter, (Millipore Corp., Bedford, MA) having
capacity to concentrate particles above 300 kDa and
aliquotes were frozen at -800C.
Lymphoproliferation and infection of PBMCs with
PPRV: For studying immunosuppressive effect of PPRV,
4x106 PBMCs/well were cultured in 24 well cell culture
plates and were infected with MOIs of 0.016, 0.1, 0.25,
0.5, 0.75 and 1. Moreover, 99 μl of 6-fold concentrated
PPRV (MOI 0.016), NPPRV and ∆420-525NPPRV were
added to duplicate wells with PBMCs. Further, PPRV
(unconcentrated) was added at MOIs of 0.1, 0.25, 0.5,
0.75 and 1. Similar volumes of lysates of Vero
(concentrated or unconcentrated) and SF21
(concentrated) cells were also added to control wells.
PBMC were stimulated with Phytohaemagglutinin from
Phaseolus vulgaris (Sigma-Aldrich, Inc., USA) at final
concentration of 3.5 μg/ml and incubated.
Lymphoproliferation was evaluated 72 hours later by
flow cytometry. Whereas, for infection of PBMCs with
PPRV, 1x106 PBMCs/well were cultured in 48 well cell
culture plates, stimulated with PHA at the concentration
of 5 μg/ml and infected four hours later with PPRV
(unconcentrated) at MOIs of 0.1, 0.5, and 1.
Flow Cytometry: The relative expression of PPRV
nucleoprotein was used as a measure of infection of
PBMCs with PPRV. The expression of the protein was
quantified by immunofluorescence staining and reading
by flow cytometry. Seventy-eight hours post infection;
the cells were plated in 96-well cell culture plate. They
were permeabilized with 3% saponine (w/v) in PBS 0.1%
Sodium azide and 5% horse serum. The cells were first
reacted with anti-NPPRV MAB 38.4 (Libeau et al., 1995)
and later with anti-mouse fluorescein-conjugated
secondary antibody IgG (Bio-Rad). The plates were
agitated for 30 minutes at 4°C and were washed twice at
the end of each incubation. Finally, cells were fixed with
1% paraformaldehyde. The expression of viral
nucleoprotein expression was measured by flow
cytometry using a FACSort (Becton Dickinson). The
analysis was done using the CELLQuestTM software
(BD Bioscience).
For lymphoproliferation studies, lymphocyte
population in the PBMCs was characterized by using
FSC (Forward scatter) and SSC (Side scatter) parameters
of size and granularity of cells. The cell population was
separated by R1 gate representing the debris and R2 gate
representing lymphocytes. Later, proportion of
lymphocytes undergoing blastogenesis in the “lower
right” window, were used for calculation of percentage of
inhibition by using following formula: [1-Test/control x
100].
RESULTS
PPRV infects PBMCs of goat: In order to evaluate
ability of Vero cell adapted Nigeria 75/1 strain of PPRV
to infect lymphocytes of naïve goats in vitro, PBMCs,
with or without mitogen stimulation, were put in contact
with PPRV. Moreover, lysates of Vero and SF21 cell
lines were also added as controls and both did not have
any negative effect upon lymphoproliferation. It was
found that unstimulated PBMCs are less susceptible to
PPRV infection than PHA activated lymphocytes. A dose
dependent increase in proportion of infected PBMCs is
seen in non-stimulated PBMCs. At the highest MOI used,
virus could infect only 32 % of the non-stimulated cells.
At the lowest MOI of 0.1, PPRV could infect 83.6% of
PHA stimulated PBMCs (Fig. 1). Using higher MOIs did
not improve infectivity. Infection after 24 and 72 hours
after mitogen stimulation also did not improve infectivity
of PBMCs (data not shown).
Figure 1: Infection of PHA stimulated and non-stimulated PBMCs at various MOIs of PPRV
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Presence of SLAM or CD150 receptor enhances
infectivity of cells by PPRV: Next, infectivity of Vero
(without SLAM), B95a (having Marmoset SLAM) and
Vero.DogSLAMtag (having canine SLAM) with wild-
type Ethiopia-94/1 and attenuated Nigeria 75/1 strains of
PPRV was tested. Both strains were serially ten-fold
diluted in DMEM and transferred to plates having the
three cell lines. B95a was the least sensitive, Vero was
moderately sensitive and Vero.DogSLAMtag was most
sensitive to infection by both strains of PPRV.
Vero.DogSLAMtag showed 0.8 log10 higher virus titer
than the Vero cell line. The B95a showed viral 3.6 and
3.9 log10 lesser titers than Vero. Dog SLAMtag cell line
for Ethiopia-94/1 and Nigeria 75/1 strains of PPRV,
respectively (Fig. 2).
Expression and relative quantification of recombinent
NPPRV and ∆420-525NPPRV proteins: Relative
quantities of two recombinant nucleoproteins and
NPPRV in PPR virus solutions were measured
by immunocapture ELISA (IC-ELISA). For the purpose,
equal volumes (100 μl) of 6-fold concentrated lysates of
SF21 infected with recombinent baculoviruses expressing
two proteins, along with equally concentrated lysates of
vero cells infected with PPRV were used and compared
by IC-ELISA as described elsewhere (Libeau et al.,
1994). It can be seen that ∆420-525NPPRV was much
better expressed as compared to NPPRV (Fig. 3). The
concentration of ∆420-525NPPRV is almost equivalent to
PPRV MOI of 0.001. Difference in expression level of
two recombinant proteins is probably due to culture
conditions.
PPRV and NPPRV inhibit the proliferation of PHA
stimulated PBMCs of goats: PPRV (unconcentrated)
could completely inhibit blastogenesis by lymphocytes
under the influence of PHA (Fig. 4). In fact, inhibition at
MOIs 0.75 and 1 was greater than what was found in
negative control i.e. PBMCs not under the influence of
mitogen but having low level blastogenesis due to auto-
stimulation. Both NPPRV and ∆420-525NPPRV proteins
could inhibit lymphoproliferation in vitro. However,
inhibition was 2.36 times higher by ∆420-525NPPRV
protein. An equal volume of 5-fold concentrated PPRV
solution (MOI 0.016) could inhibit lymphoproliferation
to 17.6 % which almost equal to what was found for
∆420-525NPPRV.
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Figure 2: PPRV (Ethiopia 94/1 and Nigeria 75/1) titration using B-95a, Vero, and Vero. DogSLAMtag cell lines.
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Figure 4: Inhibition of PHA induced blastogenesis in PBMCs by N-PPRV, ∆420-525N-PPRV and various
multiplicities of infection (MOIs) of PPRV.
DISCUSSION
In this study, it has been shown that the vaccine
strain of PPRV (Nigeria 75/1) is capable of efficiently
infecting mitogen activated goat lymphocytes in vitro.
PPRV infects PHA activated lymphocytes more
efficiently than the unstimulated ones. PHA stimulation is
known to increase SLAM expression by lymphocytes
however, SLAM is also expressed, at lower levels, in
unstimulated cultured lymphocytes (Hamalainen et al.,
2000; Erlenhoefer et al., 2001). Lower SLAM expression
explains the lower the infectivity of unstimulated
PBMCs. The lymphocyte subpopulations have not been
studied in the present study, but morbilliviruses are
known to infect both T and B cells while PHA activates
both B and T lymphocytes (Hamalainen et al., 2000;
Erlenhoefer et al., 2001). Interestingly, although Nigeria
75/1 strain of PPRV was attenuated by blind passages on
epithelial Vero cell line (Diallo et al., 1989) but has still
retained its ability to use original SLAM receptor and
infect lymphocytes as lymphatic tissues of small
ruminants do not express the second PPRV receptor; i.e.
Nectin-4 (Birch et al., 2013). Among Morbilliviruses, the
vaccine strain of measles virus (MV) is also known to be
capable of using CD46 along with SLAM receptor
(Tatsuo et al., 2000).
Next, the efficiency three cell lines for titration
of wild-type and vaccine strains of PPRV was compared.
Despite using same viral solutions for titration of two
PPRV strains, low, moderate and high titers were
recorded on B95a, Vero and Vero.DogSLAMtag cell
lines, respectively. B95a is marmoset B-lymphoblastoid
cell line capable of attachment to a substrate surface. It is
known to be 10,000-fold more sensitive to wild-type
measles virus isolation than Vero cell line (Kobune et al.,
1990) and has been used for culture of PPRV as well
(Sreenivasa et al., 2006; Pawar et al., 2008). However, it
was found that titration on B95a gave 2.4 log10 and 2.7
log10 lower titers for Nigeria 75/1 and Ethiopia 95/1
strains respectively as compared to Vero.DogSLAMtag
cell line. Vero.DogSLAMtag, expressing canine SLAM
receptor, also showed 0.8 log10 higher titers for both virus
strains than Vero cell line.
Several factors appear to contribute in the
immunosuppression produced by Morbilliviruses.
Various viral proteins play an important role in the
immunopathogenicity. Immunosuppression is initiated
either by direct contact of viral proteins with the cells of
immune system, which may or may not be infected, as
has been shown by Heaney et al. 2002 that the F-H
complex of RPV and PPRV can inhibit bovine and
caprine PBMCs. It is also reported that the nucleocapsids
of Morbilliviruses attach with lymphocytes of their
natural hosts and induce an immunosuppression (Kerdiles
et al., 2006). The nucleoprotein of Measles virus (MeV)
has been shown to suppress B and T cell proliferation by
interacting with NR and FcγRIIB receptors (Laine et al.,
2007). The region involved in NR binding is localized
within the hyper variable C-terminal region of MeV N,
NTAIL (Laine et al., 2007). Specifically, NR binds with aa
401-420, which is well conserved among Morbillivirus
members (Diallo et al., 1994). It is also well conserved
among wild-type and vaccine MeV strains. MeV N
binding to inhibitory receptors can inhibit both cell
proliferation and antibody secretion by activated B cells
NTAIL.– NR interaction. Moreover, MeV N also binds to
FcγRIIB via NCORE. T cell proliferation is inhibited and/or
modulated by MeV N in two ways. Firstly, NTAIL may
bind to NR expressed by activated T cells to suppress
their activation and subsequent proliferation. Secondly,
NCORE can directly interact with both FcγRII and NR on
DCs to inhibit their function, including IL-12 secretion,
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thus precluding efficient activation of T lymphocytes
(Laine et al., 2007).
In this study, PPRV has been used as a model
for studying the immunosuppressive properties of the
nucleoprotein. Complete NPPRV and a truncated NPPRV
were also used to localize the region responsible for
immune suppression. One can suppose that the
biochemical and antigenic characteristics of both
recombinant and viral nucleoproteins are identical as has
been for nucleoproteins of Measles virus (Ravanel et al.,
1997). Moreover, goat lymphocytes probably also
possess NR receptor (Laine et al., 2003) and interaction
of nucleoproteins with this receptor on T and B
lymphocytes could be responsible for suppression of
lymphoproliferation of naive PBMCs stimulated with
mitogen.
The expression NPPRV and ∆420-525 NPPRV
was measured by IC-ELISA and it was seen that the latter
was better expressed and had concentration comparable
to PPR virus (MOI of 0.016) after concentration. After
expression, the truncated N protein was also tested to see
if it had the immunosuppressive properties similar to the
N-MeV. The immunosuppressive effect was observed
and it was found that the anti-proliferative property lies in
the amino acid sequence 1-420 of truncated nucleoprotein
of PPRV as is the case for other Morbilliviruses. The
variable region of C-terminal, contains highly
immunogenic sites, amino acids 520-525 for Rinderpest
virus and aa 457-472 for PPRV, which make possible the
differentiation of two viruses by indirect ELISA and
Western blot (Diallo et al., 1994; Choi et al., 2003; Choi
et al., 2004; Dechamma et al., 2006). The recombinant
∆420-525 NPPRV has retained its immunosuppressive
capacity even after deletion. This suggests that the
epitopes of nucleoprotein of Morbilliviruses implicated
for immune activation are different from those which
recognize the cellular receptors responsible immune
suppression. This may explain the coexistence of two
mechanisms occurring during acute Morbillivirus
infections. Thus after initial immune suppression the host
develops a strong lifelong immunity against reinfection.
The immunosuppressive effect of ∆420-525
NPPRV was apparently greater than what was seen for
the NPPRV.  A better immune suppression may also have
come from better expression of the ∆420-525 NPPRV
and difference of molar quantities of two proteins which
engage the host receptors. As the molar mass of ∆420-
525 NPPRV is about 45 kDa where as that of NPPRV is
around 60 kDa, which becomes a quantity about ¼ times
greater. Therefore more NPPR has to be added to have an
effect equal to truncated N. Interestingly, Morbilliviruses
inactivated by ultraviolet rays, including PPRV, are
known to be immune suppressive however in our study
heat inactivated PPRV did not inhibit
lymphoproliferation but in fact stimulated
lymphoproliferation (data not shown).
Since both recombinent proteins were not HIS-
Tagged therefore it was not possible to purify these
proteins and lysates of SF21 infected with two
baculoviruses were used. In future to identify exact zone
on NPPRV which is immune suppressive, higher
concentrations of viral protein purified by his-tag will be
needed. Moreover, multiple deletions on various zones of
NPPRV will have to be tested to specify exact zone of
NPPRV which inhibits lymphoproliferation. However, it
needs to be seen whether deletions in other parts may
change the tertiary structure of the protein which may
change its properties. However, after a single deletion in
aa 420-525, truncated NPPRV retains its
immunosuppressive properties. Preparation of
recombinant PPRV with the deletion of
immunosuppressive zone of NPPRV, will reduce the
immunosuppresive nature of the current Nigeria 75/1
vaccine. The part of C-terminal part of N protein of
Morbilliviruses in association with P protein, is needed
during viral transcription (Harty and Palese, 1995;
Bankamp et al., 1996; Liston et al., 1997). It may
therefore be necessary to introduce a modified N gene by
inverse genetics in the complete genome of PPRV and
ensuring that it remains functional with the help of a
minigenome having a reporter gene like eGFP to
determine the effects of the deletion.
Conclusion: PPRV is lymphotropic as vaccine strain of
PPRV (Nigeria 75/1) is capable of infecting mitogen
activated PBMCs and that presence of canine SLAM in
Vero cell line greatly enhances infectivity as compared to
SLAM negative Vero. Vero.DogSLAMtag is more
sensitive cell line for PPRV titration and PPRV isolation.
Vaccine strain of PPRV and recombinant N-proteins
induce in vitro inhibition of cell proliferation of PBMCs
of naive goats. The deleted mutants of this protein
expressed in baculovirus system, allowed us to localize
the amino acid sequence of the truncated N-protein of
PPRV between 1-420 to be responsible for inducing
immune suppression, like N-protein of other
Morbilliviruses. Further studies are needed using multiple
deletions in the aa 1-420 of NPPRV to localize
immunosuppressive fragment which may be deleted in
future recombinant vaccines to avoid immunosuppressive
effects produced by current vaccine strains of PPRV.
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